FEATURED
AbbVie Announces Positive Results from Phase 3 Trial for Parkinson’s Disease Monotherapy
AbbVie has reported positive topline results from its pivotal Phase 3 TEMPO-1 trial evaluating tavapadon as a monotherapy for early-stage
DEALS
insitro and Lilly Forge Partnerships to Advance AI-Powered siRNA Drugs for Metabolic Diseases
Insitro, a leading AI-driven drug discovery and development company, has entered into three strategic agreements with Eli Lilly and Company
PRESS RELEASES
Revolutionising Pharmaceutical Compliance and Monitoring
The AiroSensor by SenseAnywhere is setting a new standard in compliance and environmental monitoring for the pharmaceutical industry. With a
EDITOR’S PICKS
Google DeepMind Unveils AlphaProteo: A Revolutionary AI for Protein Design
Google DeepMind has introduced AlphaProteo, an advanced AI system designed to generate novel proteins that bind to specific molecular targets.
RESOURCES
Novel T Cell Staining Reagents Revolutionise Antigen-Specific T Cell Detection
Next-level T Cell Staining with imusyn’s Dyemer & myDyemer Reagents An imusyn Flyer Groundbreaking T Cell staining reagents designed for
MANUFACTURING PROJECTS
Infrareal to Take Over Takeda’s Gene and Cell Therapy Site in Orth, Austria
Infrareal Holding plans to take over Takeda’s pharma and biotech site specialising in gene and cell therapies in Orth, Lower
CLINICAL TRIALS
AstraZeneca’s Truqap Demonstrates Phase 3 Success in Prostate Cancer
AstraZeneca’s Truqap (capivasertib) has achieved a significant milestone in the treatment of prostate cancer. Results from the CAPItello-281 Phase III
REGULATORY
Novavax Secures EC Approval for Updated 2024-2025 COVID-19 Vaccine
The leading global biotechnology company advancing protein-based vaccines, Novavax, announced that the European Commission has granted Marketing Authorisation for the
SELECTED PRODUCTS
Fast High-Throughput Microsomal Binding Assay
This high-throughput microsomal binding assay, requires only 20 min to measure the affinity of drugs to human microsomal membranes and